FI940424A - Esterderivat av hexahydroanftalen, deras framställning och deras terapeutiska användningar - Google Patents

Esterderivat av hexahydroanftalen, deras framställning och deras terapeutiska användningar Download PDF

Info

Publication number
FI940424A
FI940424A FI940424A FI940424A FI940424A FI 940424 A FI940424 A FI 940424A FI 940424 A FI940424 A FI 940424A FI 940424 A FI940424 A FI 940424A FI 940424 A FI940424 A FI 940424A
Authority
FI
Finland
Prior art keywords
preparation
hydrogen
formula
ester derivatives
therapeutic uses
Prior art date
Application number
FI940424A
Other languages
English (en)
Finnish (fi)
Other versions
FI940424A0 (sv
Inventor
Sadao Ishihara
Hiroshi Kogen
Teiichiro Koga
Eiichi Kitazawa
Nobufusa Serizawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of FI940424A0 publication Critical patent/FI940424A0/sv
Publication of FI940424A publication Critical patent/FI940424A/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734Ethers
    • C07C69/736Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
FI940424A 1993-01-29 1994-01-28 Esterderivat av hexahydroanftalen, deras framställning och deras terapeutiska användningar FI940424A (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1306393 1993-01-29

Publications (2)

Publication Number Publication Date
FI940424A0 FI940424A0 (sv) 1994-01-28
FI940424A true FI940424A (sv) 1994-11-07

Family

ID=11822687

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940424A FI940424A (sv) 1993-01-29 1994-01-28 Esterderivat av hexahydroanftalen, deras framställning och deras terapeutiska användningar

Country Status (22)

Country Link
US (1) US5491167A (sv)
EP (1) EP0609058B1 (sv)
JP (1) JPH06279280A (sv)
KR (1) KR100293335B1 (sv)
CN (1) CN1070487C (sv)
AT (1) ATE174324T1 (sv)
AU (1) AU664323B2 (sv)
CA (1) CA2114450A1 (sv)
CZ (1) CZ285658B6 (sv)
DE (1) DE69415050T2 (sv)
DK (1) DK0609058T3 (sv)
ES (1) ES2126057T3 (sv)
FI (1) FI940424A (sv)
HK (1) HK1011678A1 (sv)
HU (1) HU221852B1 (sv)
IL (1) IL108432A (sv)
NO (1) NO300769B1 (sv)
NZ (1) NZ250771A (sv)
PH (1) PH31662A (sv)
RU (1) RU2114101C1 (sv)
TW (1) TW411337B (sv)
ZA (1) ZA94548B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ250609A (en) * 1992-12-28 1995-07-26 Sankyo Co Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
US6043064A (en) * 1993-10-22 2000-03-28 Bristol-Myers Squibb Company Enzymatic hydroxylation process for the preparation of HMG-CoA reductase inhibitors and intermediates thereof
US5942423A (en) * 1995-06-07 1999-08-24 Massachusetts Institute Of Technology Conversion of compactin to pravastatin by actinomadura
US7115663B2 (en) * 2000-09-06 2006-10-03 Emisphere Technologies, Inc. Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
AR066148A1 (es) 2007-04-27 2009-07-29 Actelion Pharmaceuticals Ltd Derivados puenteados de ciclohexeno bloqueadores del canal de calcio

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
JPS57185275A (en) * 1981-05-07 1982-11-15 Sankyo Co Ltd Tetrahydro-dum-4 and tetrahydro-isodum-4 and their derivatives
US4668699A (en) * 1985-08-05 1987-05-26 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4937264A (en) * 1986-05-05 1990-06-26 Merck & Co., Inc. Antihypercholesterolemic compounds
US4937263A (en) * 1986-05-05 1990-06-26 Merck & Co., Inc. Antihypercholesterolemic compounds
US4876279A (en) * 1986-05-05 1989-10-24 Merck & Co., Inc. Antihypercholesterolemic compounds
US4902709A (en) * 1987-03-17 1990-02-20 Merck & Co., Inc. Novel antihypercholesterolemic compounds
US4885314A (en) * 1987-06-29 1989-12-05 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4997848A (en) * 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
US4946864A (en) * 1988-02-01 1990-08-07 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US5021453A (en) * 1988-03-02 1991-06-04 Merck & Co., Inc. 3-keto HMG-CoA reductase inhibitors
US5180589A (en) * 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
US4963538A (en) * 1988-06-29 1990-10-16 Merck & Co., Inc. 5-oxygenated HMG-CoA reductase inhibitors
US5130306A (en) * 1989-03-13 1992-07-14 Merck & Co., Inc. 5-Oxygenated HMG-COA reductase inhibitors
US5010105A (en) * 1989-06-09 1991-04-23 Merck & Co., Inc. Antihypercholesterolemic compounds
US5102911A (en) * 1989-06-09 1992-04-07 Merck & Co, Inc. 4-Substituted HMG-CoA reductase inhibitors
EP0415488B1 (en) * 1989-08-31 1994-04-20 Merck & Co. Inc. 7-Substituted HMG-COA reductase inhibitors

Also Published As

Publication number Publication date
ZA94548B (en) 1994-08-29
DE69415050D1 (de) 1999-01-21
FI940424A0 (sv) 1994-01-28
DE69415050T2 (de) 1999-08-12
EP0609058B1 (en) 1998-12-09
IL108432A0 (en) 1994-04-12
CN1070487C (zh) 2001-09-05
EP0609058A3 (en) 1995-04-19
NZ250771A (en) 1995-07-26
JPH06279280A (ja) 1994-10-04
AU664323B2 (en) 1995-11-09
CA2114450A1 (en) 1994-07-30
HU221852B1 (hu) 2003-02-28
HK1011678A1 (en) 1999-07-16
CN1098099A (zh) 1995-02-01
NO940309L (no) 1994-08-01
CZ18694A3 (en) 1995-03-15
PH31662A (en) 1999-01-12
NO300769B1 (no) 1997-07-21
CZ285658B6 (cs) 1999-10-13
KR940018352A (ko) 1994-08-16
ATE174324T1 (de) 1998-12-15
AU5472894A (en) 1994-08-04
KR100293335B1 (ko) 2001-09-17
EP0609058A2 (en) 1994-08-03
TW411337B (en) 2000-11-11
NO940309D0 (no) 1994-01-28
US5491167A (en) 1996-02-13
DK0609058T3 (da) 1999-08-16
ES2126057T3 (es) 1999-03-16
RU2114101C1 (ru) 1998-06-27
HUT67740A (en) 1995-04-28
HU9400242D0 (en) 1994-05-30
IL108432A (en) 1997-09-30

Similar Documents

Publication Publication Date Title
FI935895A (sv) Hexahydronaftalenderivat, deras framstaellning och deras terapeutiska anvaendningar
SE503618C2 (sv) Antihyperkolesterolemiska tetrazolföreningar
AU636351B2 (en) N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments
ES8706144A1 (es) Un procedimiento para preparar derivados de 1,8-naftiridina
FI940424A0 (sv) Esterderivat av hexahydroanftalen, deras framställning och deras terapeutiska användningar
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
ES2054828T3 (es) Acidos n-(bifenilmetil)-3-hidroxiglutaramicos y sus derivados como agentes hipocolesterolemicos.
NO941757L (no) 1-fenylpyrrolidon-derivater med optisk aktivitet, mellomprodukter for fremstilling derav og fremgangsmåter for deres fremstilling
DE69006038D1 (de) 1,3-Dioxolan-benzoesäure und Derivate davon.